Key facts
- This page summarizes Allan R. Will's Form 4 filing for Fractyl Health, Inc. (GUTS).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 05 Feb 2024, 17:10.
Allan R. Will - 01 Feb 2024 Form 4 Insider Report for Fractyl Health, Inc. (GUTS)
- Reporting relationship
- Director
- Issuer ticker
- GUTS
- Reported as of
- 01 Feb 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 05 Feb 2024, 17:10:33 UTC
- Next SEC filing
- 22 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Lisa A. Davidson, Attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Allan R. Will filed Form 4 for Fractyl Health, Inc. (GUTS) on 05 Feb 2024.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
GUTS
transaction
Derivative
Stock Option
Award
- Transaction value
- $0
- Shares
- +45,000
- Change %
- Price
- $0.000000
- Shares after
- 45,000
- Date
- 01 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 45,000
- Exercise price
- $15.00
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The stock option vests in three annual installments beginning on February 1, 2025.